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EDITORIAL
Establishing a role for sphingolipids in renal injury and stress
responses
The once polemical concept that cellular lipids might serve as
substrates for the generation of cellular second messengers is now
accepted as scientific truth. The hydrolysis by phospholipases or
the phosphorylation by lipid kinases of glycerophospholipids
creates a legion of second messengers with an impressive range of
cellular targets and functions. Recently, another class of lipids, the
sphingolipids, has been identified as potential mediators of cell
signaling functions. These lipids are characterized by the presence
of a long chain aliphatic amine, typically sphingosine. When this
long chain base is acylated in amide linkage, ceramide is formed.
Ceramide in turn is the substrate for a variety of products
including the phospholipid sphingomyelin, ceramide-1-phosphate,
1-O-acylceramide, and over 300 glycosphingolipids, both neutral
and acidic. Sphingosine can also be phosphorylated forming
sphingosine-1-phosphate or methylated forming N,N-dimethyl-
sphingosine [1].
Various roles have been proposed for many of these metabo-
lites, and for many proposed functions, such as the binding of
bacteria, viruses, or bacterial toxins to cell surface glycosphingo-
lipid receptors, strong proof of concept exists. For example, the
verotoxin of E. coli binds specifically to globotriosylceramide, thus
mediating the pathology of hemolytic uremic syndrome. For other
sphingolipids, proof of concept has yet to be established.
Among the myriad of sphingolipids, ceramide has received the
greatest attention as a potential signaling molecule. Following
exposure to agonists such as tumor necrosis factor-alpha (TNF-a),
interleukin-1 (IL-1), nerve growth factor (NGF), or Fas ligation,
some but not all cells exhibit activation of either an acidic or
neutral sphingomyelinase and accumulation of ceramide [2].
Other cell stressors are also associated with ceramide accumula-
tion including heat shock or toxin exposure. In many of these
settings there is concomitant activation of the stress-activated
protein (SAP) kinase cascade. Because of the nature of the
agonists and the cellular pathways stimulated, investigators have
proposed a more general role for ceramide as a mediator of the
cellular stress response.
In this issue of Kidney International, Zager and colleagues
report on ceramide levels and sphingomyelinase activity in three
models of acute renal failure [3]. In ischemia/reperfusion, glycer-
ol-induced myoglobinuria, and alpha glomerular basement mem-
brane (aGBM) nephritis, levels of ceramide increase almost
twofold in mouse renal cortices over control. Interestingly, isch-
emia/reperfusion and myoglobinuria were associated with de-
pressed sphingomyelinase activities while sphingomyelinase activ-
ity increased in the aGBM nephritic mice. These observations not
only raise the possibility that ceramide is an important signal for
renal injury or stress, but suggest that pathways for ceramide
metabolism other than sphingomyelin hydrolysis (including de
novo synthesis and degradation) may by critically regulated.
Several questions must be addressed prior to establishing proof
of concept for a critical role for ceramide formation in renal
injury. First, is ceramide the key mediator of the ischemic
response? The cellular response to cell permeable short chain
ceramides is often cited as proof for a critical role for ceramide in
signaling responses. These truncated ceramides, however, are
avidly metabolized to other short chain sphingolipids and to
normal chain length lipids following deacylation [4]. They also act
as potent detergents on cell membranes and thus may induce a
stress response independent of activating specific cellular targets.
If ceramide is formed de novo in ischemia/reperfusion, then
cellular concentrations of precursors and products of ceramide
metabolism will also change. Free sphingosine, for example, was
identified in earlier studies as a potent inhibitor of protein kinase
C as is the sphingosine metabolite N,N-dimethylsphingosine [5].
More importantly, sphingosine-1-phosphate, the product of sphin-
gosine kinase, is a potent stimulus cellular growth and appears to
be a critical signal in the stress response of S. cervesiae.
Second, what cellular targets for ceramide or ceramide metab-
olites mediate the stress response? Several such targets have been
proposed including protein phosphatase 2a, kinase suppressor of
Ras, SAP kinase, and NF-kB [6]. In some cases, such as NF-kB
activation, compelling evidence against a role for ceramide sig-
naling exists. In other cases, there is no consensus that putative
targets are ceramide activated.
Third, what is the functional importance for ceramide or other
sphingolipids in the cellular injury or stress response? On the one
hand, ceramide is proposed to be a mediator of apoptosis. Fas
activation, radiation-induced cell death, and chemotherapeutic
agents have all been suggested to signal through ceramide forma-
tion. On the other hand, when ceramide is formed it is most often
formed late, that is, often after those signaling events that initiate
the apoptotic response [6]. In addition, ceramide is formed during
heat shock and appears to mediate the transcription of some heat
shock proteins [7]. Sphingolipid deficient S. cervesiae grow nor-
mally but lack the ability to survive heat shock or nutrient
deprivation [8]. Until there is a better comprehension of the basis
for these disparate findings, the functional role of ceramide in cell
signaling will remain an enigma.
Addressing these and other fundamental questions in sphingo-
lipid function has been hindered by the lack of suitable reagents in
the form of cDNA of enzymes in the biosynthetic pathway for
sphingolipids and selective inhibitors of sphingolipid metabolism.
Recently, however, significant progress has been made in both
endeavors. As cellular targets for sphingolipids are definitively
identified, and as the means are developed for selectively and© 1998 by the International Society of Nephrology
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specifically regulating endogenous levels of sphingolipids, proof of
concept for sphingolipid-mediated signaling in cellular stress
response and injury may eventually be established.
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